PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

CathWorks-PROVISION

More Like This

PR Newswire associated0

CathWorks Announces Key Events for EuroPCR 2025

PR Newswire associated0

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

PR Newswire associated0

CathWorks Announces EU MDR Approval, Prominent Presence at EuroPCR and Full Launch of Co-promotion

PR Newswire associated0

MedHub-AI and Terumo partner to market AI-based FFR in Japan

PR Newswire associated0

Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial

PR Newswire associated0

FLEX Vessel Prep™ System FLEX FIRST AV Registry 6-Month Data and the Hamburg Vessel Prep Experience Prior to Angioplasty presented at Charing Cross Symposium

PR Newswire associated0

Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor

Business Wire logo

CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients